Roche Tecentriq cocktail shows progression-free survival in melanoma patient Medical Dialogues Bureau14 Dec 2019 9:20 AM ISTRoche has an extensive clinical trial development programme for Tecentriq, with more than 50 studies for use in fighting lung, kidney, skin, breast,...
Sanofi, Biocorp enter partnership to fit SoloStar insulin pens with Mallya technology Medical Dialogues Bureau14 Dec 2019 9:15 AM ISTThis long-term agreement is the first decision resulting from exclusive negotiations initiated in July 2019. Sanofi and Biocorp are thus fulfilling...
Biocon, Equillium expand license agreement for plaque psoriasis drug Itolizumab Farhat Nasim13 Dec 2019 3:37 PM ISTEquillium had originally secured exclusive rights to develop and commercialize Biocon Ltd’s novel biologic, Itolizumab, for the U.S. and Canada...
Hikal Gujarat facility gets EIR from USFDA Farhat Nasim13 Dec 2019 3:07 PM ISTThe pharmaceutical manufacturing facility at Panoli in Gujarat was recently inspected by the US Food and Drug Administration (USFDA) in compliance...
New Delhi: Elderly chemist murdered by Gym Trainer allegedly over purchase of viagra Farhat Nasim13 Dec 2019 1:32 PM ISTNew Delhi: In a shocking incident, a 50-year-old chemist was allegedly murdered by a gym trainer following an altercation over the purchase of viagra...
Aurobindo Pharma arm recalls 59k vials of antipsychotic Fluphenazine Decanoate injection from US Medical Dialogues Bureau13 Dec 2019 9:30 AM ISTAurobindo Pharma arm AuroMedics Pharma LLC is recalling 59,500 vials of the injection on account of "Discoloration; hazy solution found in one vial...
Sarepta Therapeutics newest DMD treatment Vyondys 53 gets early USFDA nod Medical Dialogues Bureau13 Dec 2019 9:30 AM IST Sarepta Therapeutics said the new treatment Vyondys 53 is priced at parity to its first DMD drug, Exondys 51, which is priced at about $300,000 per...
Cipla associate Avenue Therapeutics files US application for IV tramadol Farhat Nasim12 Dec 2019 3:30 PM ISTNew Delhi: Cipla Ltd's associate company, Avenue Therapeutics, Inc. ("Avenue"), a company focused on the development of intravenous ("IV") tramadol...
Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M Medical Dialogues Bureau12 Dec 2019 11:53 AM ISTAhmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
Mumbai-based Eurolife Healthcare to infuse Rs 100 crore for expanding production Medical Dialogues Bureau12 Dec 2019 9:30 AM ISTAs a first step, the company has signed up a deal with a Chinese firm for procuring high-speed machines which would enable Eurolife manufactures the...
Sanofi, Regeneron to restructure antibody collaboration for Kevzara, Praluent Farhat Nasim12 Dec 2019 9:20 AM ISTUnder the proposed restructuring, Sanofi is expected to gain sole global rights to Kevzara and sole ex-U.S. rights to Praluent. Regeneron is expected...
AstraZeneca-Daiichi trastuzumab deruxtecan halts cancer for months in first readout Medical Dialogues Bureau12 Dec 2019 9:05 AM IST"This is a totally unprecedented clinical benefit," Jose Baselga, AstraZeneca's head of oncology research and development said of the so-called...
